ClinicalTrials.Veeva

Menu
C

Clintrial s.r.o. | Prague, Czech Republic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TAK-279
Atogepant
BI 1358894
Tavapadon
KarXT
BOTOX
BI 1569912
ACP-204
LY4100511
Lu-AG09222

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

13 of 30 total trials

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (PROCEED)

The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have alread...

Active, not recruiting
Migraine
Drug: Placebo
Drug: Lu AG09222
Locations recently updated

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Enrolling
Atopic Dermatitis
Eczema Atopic Dermatitis
Drug: Placebo
Drug: Camoteskimab

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Enrolling
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo
Locations recently updated

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Active, not recruiting
Plaque Psoriasis
Drug: TAK-279

This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Al...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: Placebo
Drug: KarXT

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Active, not recruiting
Prurigo Nodularis
Drug: Placebo
Drug: Povorcitinib

The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.

Enrolling
Migraine
Drug: Placebo
Drug: MEDI0618

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...

Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204

Atopic dermatitis is an ongoing condition that causes skin irritation, redness, and itchiness. Treatments are usually topical - applied to the skin (...

Enrolling
Moderate to Severe Atopic Dermatitis
Drug: Methotrexate
Drug: Placebo
Locations recently updated

This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN0...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: KarXT

A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often accompanied by throbbing, sensitivity to...

Active, not recruiting
Migraine
Drug: Placebo for Atogepant
Drug: Atogepant

A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often throbbing or pulsating. The headache is o...

Active, not recruiting
Menstrual Migraine (MM)
Drug: Placebo for Atogepant
Drug: Atogepant

Trial sponsors

AbbVie logo
Boehringer Ingelheim logo
Lundbeck logo
Takeda logo
K
Acadia Pharmaceuticals logo
A
A
D
Genentech logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems